Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 9/20 | 0.49 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.49 |
| ▸ | WNT1 | P04628 | 3/20 | 0.47 |
| ▸ | GSK3B | P49841 | 3/20 | 0.47 |
| ▸ | DYRK1A | Q13627 | 3/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | CLK2 | P49760 | 1/20 | 0.45 |
| ▸ | CLK3 | P49761 | 1/20 | 0.45 |
| ▸ | MAOA | P21397 | 2/20 | 0.44 |
| ▸ | MAOB | P27338 | 2/20 | 0.44 |
| ▸ | F10 | P00742 | 1/20 | 0.42 |
| ▸ | DRD1 | P21728 | 1/20 | 0.42 |
| ▸ | DRD5 | P21918 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23077104 | 0.84 | HDAC6 (0.52) | HDAC6HDAC8WNT1GSK3BDYRK1A | |
| SCHEMBL26484688 | 0.83 | HDAC6 (0.51) | HDAC6HDAC8WNT1GSK3BDYRK1A | |
| SCHEMBL30839551 | 0.79 | ALDH1A1 (0.61) | HDAC6HDAC8MAOAMAOBF10 | |
| SCHEMBL3313430 | 0.79 | ALDH1A1 (0.61) | HDAC6HDAC8MAOAMAOBF10 | |
| SCHEMBL12039308 | 0.79 | MAOA (0.52) | HDAC6HDAC8MAOAMAOBF10 | |
| SCHEMBL3440249 | 0.79 | HDAC6 (0.54) | HDAC6HDAC8WNT1GSK3BDYRK1A | |
| SCHEMBL26487314 | 0.78 | NAMPT (0.55) | — | |
| SCHEMBL20119170 | 0.78 | USP5 (0.47) | HDAC6HDAC8WNT1GSK3BDYRK1A | |
| SCHEMBL3307342 | 0.78 | DRD1 (0.51) | HDAC6HDAC8MAOAMAOBDRD1 | |
| SCHEMBL30620400 | 0.78 | HSD17B3 (0.55) | HDAC6HDAC8MAOAMAOBF10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018081285-A1 | UREA-CONTAINING ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF | ENANTA PHARMACEUTICALS, INC. (US) | 2018-05-03 | — | — | WO | disclosed |